** = Publikationen gelistet in SCI/SSCI/Pubmed
** Vejzovic, D; Kubin, A; Fechter, K; Karner, C; Hartmann, J; Ackerbauer, T; Radović, B; Ritter, G; Üçal, M; Ropele, S; Ali, KM; Mischkulnig, M; Leoni, M; Liegl-Atzwanger, B; Wightman, L; Rinner, B
Glioblastoma targeting by water-soluble hypericin derivate HHL-PVP and photodynamic tumour killing.
Biomed Pharmacother. 2025; 186:118041
Doi: 10.1016/j.biopha.2025.118041
PubMed
FullText
FullText_MUG
** Wurbs, A; Karner, C; Vejzovic, D; Singer, G; Pichler, M; Liegl-Atzwanger, B; Rinner, B
A human ex vivo skin model breaking boundaries.
Sci Rep. 2024; 14(1): 24054
Doi: 10.1038/s41598-024-75291-7
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Karner, C; Anders, I; Vejzovic, D; Szkandera, J; Scheipl, S; Deutsch, AJA; Weiss, L; Vierlinger, K; Kolb, D; Kühberger, S; Heitzer, E; Habisch, H; Zhang, F; Madl, T; Reininger-Gutmann, B; Liegl-Atzwanger, B; Rinner, B
Targeting epigenetic features in clear cell sarcomas based on patient-derived cell lines.
J Transl Med. 2023; 21(1): 54
Doi: 10.1186/s12967-022-03843-4
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Schrom, S; Kleinegger, F; Anders, I; Hebesberger, T; Karner, C; Liesinger, L; Birner-Gruenberger, R; Renner, W; Pichler, M; Grillari, R; Aigelsreiter, A; Rinner, B
MUG CCArly: A Novel Autologous 3D Cholangiocarcinoma Model Presents an Increased Angiogenic Potential.
Cancers (Basel). 2023; 15(6): 1757
Doi: 10.3390/cancers15061757
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG